Delivery Order SPE2DB24D2205-SPE2DB25FEGGJ
- Not listed
- The Defense Logistics Agency awarded a $25,771.74 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Ofev 150 mg capsules (60-count units). The contract is scheduled for completion by October 8, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside, competitively awarded delivery order representing a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Ofev 150 mg capsules (60-count units) with a contract ceiling value of $34,362.32. This firm fixed-price delivery order, with an ultimate completion date of October 6, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work...
- The Defense Logistics Agency awarded a $8,630.28 delivery order contract to AmerisourceBergen Drug Corp for the supply of Ofev 100 mg capsules (60-count units) on July 15, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price contract was competitively awarded without set-aside restrictions and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Ofev 150 mg capsules (60-count units) valued at $17,181.16. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by September 26, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Ofev 150 mg capsules. The contract has a ceiling value of $7,905.56 and a performance period ending on May 3, 2024. This order is part of Amerisourcebergen's prime contractor role on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ofev 150 mg capsules in a quantity of 60 units. This firm fixed-price delivery order, valued at $8,590.58, represents a non-competitive award and is scheduled for completion by September 22, 2025. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Ofev 100 mg capsules (60-count) with a ceiling value of $8,630.28. This firm fixed-price delivery order is set to be completed by September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, demonstrating AmerisourceBergen's continued capability to meet federal...
- The Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $51,662.58 on August 13, 2025, for the supply of Ofev 100 mg capsules (60-count units). This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by September 4, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $17,220.86 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Ofev 100 mg capsules (60-count units). This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. This delivery order is...
- The Defense Logistics Agency awarded a $42,952.90 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ofev 150 mg capsules (60-count units). The contract, which is not set-aside, carries a firm fixed price structure and a completion date of August 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award represents a child contract under AmerisourceBergen's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGGJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $25,771.74 to AmerisourceBergen Drug Corp for the supply of Ofev 150 mg capsules (60-count units). This firm fixed-price, non-set-aside contract was competitively awarded on August 14, 2025, with an ultimate completion date of September 5, 2025. The pharmaceutical products will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare procurement. The company holds a significant prime contract vehicle that enables it to supply a broad range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and the U.S. Coast Guard, positioning AmerisourceBergen as a key provider within the DLA Medical Supply Chain for ongoing pharmaceutical support to the Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.8k | 8/14/25 |